Pressure ulcers (PUs) develop when pressure, shear, friction, or excess moisture and heat is
applied to skin, disrupting blood flow and breaking down the skin & underlying tissue. In the
UK >700,000 people per year are affected by PUs costing the NHS £2.8Bn pa.(1)
Many people at risk of developing PUs, specifically elderly or ‘plus sized’ people (also
defined as obese, morbidly obese or bariatric) with reduced mobility, increased metabolic
needs and different adipose tissue composition. The impact of excessive moisture and heat at
the skin is of particular concern for plus sized people (2,5).
Plus size people often use a recliner as their main domestic furniture for rest & sleep, as lying
flat may compromise their resting breathing (Muir and Rush,19).
Currently, there are no commercially available pressure redistributing devices (PRDs) for use
on Recliners that have intrinsic microclimate control properties. In this 18 month, £249k
Development of Prototype project, Medstrom will learn from the TSB AeroSpacer overlay
project (ML720552) to develop a prototype that deals with the very different needs of plus
size people, providing pressure reduction and maintaining optimal skin condition.
The AeroSpacer mattress provides microclimate control due to its pressure-relieving core
being manufactured from an innovative, 3D-knit spacer fabric, this enables transfer of air via
patient movement or when air is driven air through it. The core is covered with a moisturevapour
permeable fabric that enables moisture to move away from the skin. The entire unit
benefits from being fully washable. These features are unique in this type of device.
Conservative sales projections indicate that 9% of all Bariatric Recliners could be fitted with
an AeroSpacer Plus (AS+) within 5 years of project close; if the AS+ prevented PU formation
in 10% of the plus sized population (PSP) then a cost saving of £5.2M per year would be
derived for the UK(1)
70,466
2014-10-01 to 2015-11-30
GRD Development of Prototype
Pressure ulcers (PUs) break down the skin & underlying tissue, and develop when pressure,
shear & friction is applied to skin, disrupting the flow of blood through the skin, starving the
skin of oxygen & nutrients. PUs affect people confined to lying in a bed or sitting for
prolonged periods of time. 0.5 million people in the UK will develop a PU per year. PU
treatment costs the NHS over £4bn/year, and costs are increasing as the population ages.
Pressure relieving devices (PRDs) are deployed by health and social care providers, as
specialist mattresses, overlays for standard mattresses, or as complex full bed systems, to
reduce the incidence of PUs.
Raised skin temperature and increased moisture levels around patients are risk factors
implicated in the development of PUs. Temperature and moisture levels induce a
‘microclimate’ around the patient, and current medical literature suggests that microclimate
control could also help reduce the incidence of PUs.
Currently, there are no commercially available PRDs that have intrinsic microclimate control
properties. In this 15 month, £201k development of prototype project, Medstrom will develop
the ‘Aerospacer’ overlay, which enables pressure reduction and maintenance of an optimal
skin microclimate.
The Aerospacer enables microclimate control due to its pressure-relieving core being
manufactured from an innovative, 3D-woven spacer fabric which has an open core structure
permitting air to pass underneath the patient, this airflow can be augmented with driven air
provided by a low voltage fan accessory. The core is covered with a moisture-vapour
permeable fabric that enables moisture to move away from the skin. The entire unit benefits
from being fully washable.
Conservative sales projections indicate 5.5% of all NHS beds could be fitted with an
Aerospacer within 5 years of project close; if the Aerospacer prevented PU formation across
the NHS by 5.5%, a cost saving of £220M could be realised per year